Skip to main content
. 2022 Oct 21;25(Suppl 6):e26009. doi: 10.1002/jia2.26009
Abstract P201 – Table 1. Unadjusted and adjusted relative hazards of virological rebound >50 copies/mL.
Unadjusted HR (95% CI) p‐value Adjusted HRa (95% CI) p‐value
HIV+ (group A) 1 1
HCV+/HBsAg‐/HBcAb‐ (group B) 2.10 (1.61 to 2.74) <0.001 1.72 (1.27 to 2.33) <0.001
HCV‐/HBsAg‐/HBcAb+ (group C) 1.24 (1.04 to 1.47) 0.015 1.23 (1.03 to 1.47) 0.019
HCV+/HBsAg‐/HBcAb+ (group D) 2.60 (2.11 to 3.21) <0.001 2.00 (1.51 to 2.65) <0.001
HCV‐/HBsAg+/HBcAb+ (group E) 1.49 (1.07 to 2.09) 0.019 1.47 (1.05 to 2.05) 0.026

aAdjusted for nationality, and mode of transmission.